Acquired Long QT

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acquired Long QT trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07374263

Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?

There are 28 non-cardiology medications from multiple families costing more than $13 billion annually in Canada, categorized as 'Known' QT-prolonging medication…

Canada990,000 participantsStarted 2025-02-01

All recent trials (6 shown)

CompletedNot Applicable

NCT05759260

QT Interval in Athletes

QT interval prolongation occurs in athletes and causes concerns, as it may indicate the life-threatening long QT syndrome (LQTS). Clinical and genetic testing i…

Italy869 participantsStarted 2018-12-05

Treatment: Observation

UnknownPhase 4

NCT04169100

Novel Form of Acquired Long QT Syndrome

The goal of this study is to determine whether anti-Ro/SSA antibodies are associated with acquired QT prolongation in subjects with connective tissue disease. T…

United States25 participantsStarted 2011-09-28

Treatment: Prednisone

Acquired Long QT

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?

All recent trials (6 shown)

QT Interval in Athletes

Novel Form of Acquired Long QT Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?

All recent trials (6 shown)

QT Interval in Athletes

Novel Form of Acquired Long QT Syndrome

Prevalence of Congenital Long QT Syndrome and Acquired QT Prolongation in a Hospital Cohort

Does Azithromycin Cause QT Prolongation in Hospitalized Patients With Severe Community Acquired Pneumonia?

The Effect of General Anesthesia on the Risk for Arrhythmia